Low expression of SLIT1, SLIT2, and SLIT3 and high expression of ROBO1 and ROBO2 in the BM of AML patients may suggest deregulation of SLIT–ROBO pathway in AML. Here, ROBO1 is linked to acute myeloid leukemia.